相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。PROTAC targeted protein degraders: the past is prologue
Miklos Bekes et al.
NATURE REVIEWS DRUG DISCOVERY (2022)
Combating Cancer Stem-Like Cell-Derived Resistance to Anticancer Protein by Liposome-Mediated Acclimatization Strategy
Shiyang Shen et al.
NANO LETTERS (2022)
Programmed cell death 1 ligand 1 signals in cancer cells
Anand V. R. Kornepati et al.
NATURE REVIEWS CANCER (2022)
Covalent Cell Surface Conjugation of Nanoparticles by a Combination of Metabolic Labeling and Click Chemistry
Alexander Lamoot et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2021)
Development of Antibody-Based PROTACs for the Degradation of the Cell-Surface Immune Checkpoint Protein PD-L1
Adam D. Cotton et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2021)
Spatial Regulation of T-Cell Signaling by Programmed Death-Ligand 1 on Wireframe DNA Origami Flat Sheets
Trixy Fang et al.
ACS NANO (2021)
Covalently Engineered Nanobody Chimeras for Targeted Membrane Protein Degradation
Heng Zhang et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2021)
A Not-So-Ancient Grease History: Click Chemistry and Protein Lipid Modifications
Kiall F. Suazo et al.
CHEMICAL REVIEWS (2021)
ARIH1 signaling promotes anti-tumor immunity by targeting PD-L1 for proteasomal degradation
Youqian Wu et al.
NATURE COMMUNICATIONS (2021)
Living-System-Driven Evolution of Self-Assembled-Peptide Probes: For Boosting Glioma Theranostics
Mingmei Guo et al.
ANALYTICAL CHEMISTRY (2021)
Multi-stage responsive peptide nanosensor: Anchoring EMT and mitochondria with enhanced fluorescence and boosting tumor apoptosis
Yuwei Tian et al.
BIOSENSORS & BIOELECTRONICS (2021)
Aptamer-Based Logic Computing Reaction on Living Cells to Enable Non-Antibody Immune Checkpoint Blockade Therapy
Yu Yang et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2021)
WSX1 act as a tumor suppressor in hepatocellular carcinoma by downregulating neoplastic PD-L1 expression
Man Wu et al.
NATURE COMMUNICATIONS (2021)
Trends in clinical development for PD-1/PD-L1 inhibitors
Jia Xin Yu et al.
NATURE REVIEWS DRUG DISCOVERY (2020)
The structural features that distinguish PD-L2 from PD-L1 emerged in placental mammals
Elliot A. Philips et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2020)
Engineering Programmed Death Ligand-1/Cytotoxic T-Lymphocyte-Associated Antigen-4 Dual-Targeting Nanovesicles for Immunosuppressive Therapy in Transplantation
Zhanxue Xu et al.
ACS NANO (2020)
Lysosome-targeting chimaeras for degradation of extracellular proteins
Steven M. Banik et al.
NATURE (2020)
Inhibiting PD-L1 palmitoylation enhances T-cell immune responses against tumours
Han Yao et al.
NATURE BIOMEDICAL ENGINEERING (2019)
Deep Tumor Penetration of Drug-Loaded Nanoparticles by Click Reaction-Assisted Immune Cell Targeting Strategy
Soo Hong Lee et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2019)
Targeted protein degradation: expanding the toolbox
Matthieu Schapira et al.
NATURE REVIEWS DRUG DISCOVERY (2019)
A high-affinity human PD-1/PD-L2 complex informs avenues for small-molecule immune checkpoint drug discovery
Shaogeng Tang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
HIP1R targets PD-L1 to lysosomal degradation to alter T cell-mediated cytotoxicity
Huanbin Wang et al.
NATURE CHEMICAL BIOLOGY (2019)
A Ligand System for the Flexible Functionalization of Quantum Dots via Click Chemistry
Yue Chen et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2018)
Visualizing biologically active small molecules in cells using click chemistry
Tatiana Caneque et al.
NATURE REVIEWS CHEMISTRY (2018)
CMTM6 maintains the expression of PD-L1 and regulates anti-tumour immunity
Marian L. Burr et al.
NATURE (2017)
PD-1/PD-L1 binding studies using microscale thermophoresis
Romain Magnez et al.
SCIENTIFIC REPORTS (2017)
PD-L2 Expression in Human Tumors: Relevance to Anti-PD-1 Therapy in Cancer
Jennifer H. Yearley et al.
CLINICAL CANCER RESEARCH (2017)
The Added Value of Assessing Ligand-Receptor Binding Kinetics in Drug Discovery
Dong Guo et al.
ACS MEDICINAL CHEMISTRY LETTERS (2016)
Nuclear localized Akt enhances breast cancer stem-like cells through counter-regulation of p21Waf1/Cip1 and p27kip1
Mayur Vilas Jain et al.
CELL CYCLE (2015)
The dynamic control of signal transduction networks in cancer cells
Walter Kolch et al.
NATURE REVIEWS CANCER (2015)
Rapid and reversible knockdown of endogenous proteins by peptide-directed lysosomal degradation
Xuelai Fan et al.
NATURE NEUROSCIENCE (2014)
Synthetic Self-Localizing Ligands That Control the Spatial Location of Proteins in Living Cells
Manabu Ishida et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2013)
The blockade of immune checkpoints in cancer immunotherapy
Drew M. Pardoll
NATURE REVIEWS CANCER (2012)
Signalling ballet in space and time
Boris N. Kholodenko et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2010)
The promises and pitfalls of RNA-interference-based therapeutics
Daniela Castanotto et al.
NATURE (2009)
Cell Signaling in Space and Time: Where Proteins Come Together and When They're Apart
John D. Scott et al.
SCIENCE (2009)
Opinion - Drug-target residence time and its implications for lead optimization
Robert A. Copeland et al.
NATURE REVIEWS DRUG DISCOVERY (2006)
PD-L2 is a second ligand for PD-I and inhibits T cell activation
Y Latchman et al.
NATURE IMMUNOLOGY (2001)